Post Inflammatory Hyperpigmentation Completed Phase 4 Trials for Benzoyl peroxide (DB09096)

Also known as: Postinflammatory Hyperpigmentation / Post-inflammatory Hyperpigmentation / Postinflammatory hyperpigmentation (morphologic abnormality) / Post-inflammatory hyperpigmentation (disorder) / Post inflammatory pigmentation change

IndicationStatusPhase
DBCOND0045798 (Post Inflammatory Hyperpigmentation)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03402893The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of ColorTreatment